Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ACCD 
Accolade Inc (ACCD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: ACCD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -17.04% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 573.13M USD | Price to earnings Ratio - | 1Y Target Price 7.03 |
Price to earnings Ratio - | 1Y Target Price 7.03 | ||
Volume (30-day avg) 1059281 | Beta 2.19 | 52 Weeks Range 3.08 - 9.67 | Updated Date 04/1/2025 |
52 Weeks Range 3.08 - 9.67 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -40.36% | Operating Margin (TTM) -22.71% |
Management Effectiveness
Return on Assets (TTM) -7.5% | Return on Equity (TTM) -48.23% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 582695680 | Price to Sales(TTM) 1.28 |
Enterprise Value 582695680 | Price to Sales(TTM) 1.28 | ||
Enterprise Value to Revenue 1.31 | Enterprise Value to EBITDA -11.78 | Shares Outstanding 81993104 | Shares Floating 63863504 |
Shares Outstanding 81993104 | Shares Floating 63863504 | ||
Percent Insiders 3.28 | Percent Institutions 88.19 |
Analyst Ratings
Rating 3.42 | Target Price 7.06 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Accolade Inc
Company Overview
History and Background
Accolade, Inc. was founded in 2007. It provides personalized health and benefits solutions designed to help individuals navigate the complexities of healthcare and benefits programs. The company has evolved from a focus on second opinions to a broader suite of integrated healthcare services, including primary care, mental health support, and expert medical opinion.
Core Business Areas
- Personalized Healthcare: Accolade's core offering provides personalized healthcare guidance through a team of health assistants, nurses, and physicians. These teams help members navigate their benefits, understand treatment options, and coordinate care.
- Expert Medical Opinion: Connects patients with medical experts for second opinions and treatment recommendations, improving treatment decisions and outcomes.
- Primary Care and Mental Health: Offers virtual primary care and mental health services, expanding access to care and addressing key healthcare needs.
Leadership and Structure
Rajeev Singh is the current CEO. The organizational structure is based on functional areas such as technology, sales, marketing, operations, and finance. There are also product-specific teams focused on developing and managing their various healthcare solutions.
Top Products and Market Share
Key Offerings
- Accolade Health Assistant: A personalized platform that integrates health data and provides guidance to members. Accolade does not publicize specific market share for this product. Competitors include Grand Rounds Health (Included First Stop Health), Included Health, Quantum Health, and many smaller companies. It's difficult to assign distinct revenue from the product but it does make up 99% of total revenue in 2024.
- Accolade Expert MD: Provides access to specialist medical second opinions. Revenue generated is rolled into the Accolade Health Assistant product revenue. Competitors include Cleveland Clinic and Mayo Clinic and Best Doctors.
Market Dynamics
Industry Overview
The healthcare navigation and benefits solutions market is experiencing significant growth due to rising healthcare costs, increased complexity in the healthcare system, and a growing demand for personalized care. There is a push towards preventive care and patient engagement.
Positioning
Accolade is positioned as a provider of integrated personalized healthcare solutions. Their competitive advantages lie in their health assistant model that combines technology and human support, the breadth of their offerings, and their ability to integrate with existing benefits programs.
Total Addressable Market (TAM)
The estimated total addressable market (TAM) for healthcare navigation and benefits solutions is over $30 billion and Accolade is positioned to compete for a growing share of this market. They are positioned well to address a growing demand for personalized care.
Upturn SWOT Analysis
Strengths
- Personalized approach
- Integrated platform
- Strong customer relationships
- Scalable technology infrastructure
Weaknesses
- Reliance on a few large clients
- History of operating losses
- Intense competition
- Challenges in demonstrating ROI
Opportunities
- Expanding product offerings
- Entering new markets
- Acquiring complementary businesses
- Increasing adoption of value-based care
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Data security breaches
Competitors and Market Share
Key Competitors
- Quantum Health
- Included Health
- Rightway Healthcare
Competitive Landscape
Accolade faces intense competition from other healthcare navigation companies, insurance companies, and technology vendors. Their advantages lie in their personalized approach, integrated platform, and strong customer relationships. Their disadvantages include their reliance on a few large clients and their history of operating losses.
Major Acquisitions
2nd.MD
- Year: 2021
- Acquisition Price (USD millions): 460
- Strategic Rationale: The acquisition of 2nd.MD expanded Accolade's expert medical opinion capabilities and broadened its customer base.
PinnacleCare
- Year: 2021
- Acquisition Price (USD millions): 185
- Strategic Rationale: The acquisition of PinnacleCare expanded Accolade's health assistance services.
Growth Trajectory and Initiatives
Historical Growth: Accolade has experienced significant revenue growth over the past few years due to increased demand for their services and acquisitions.
Future Projections: Analysts predict continued revenue growth for Accolade as they expand their customer base and introduce new products. Profitability is expected to be achieved in the coming years.
Recent Initiatives: Recent initiatives include expanding their virtual primary care and mental health services, partnering with additional health systems, and investing in new technology to enhance their platform.
Summary
Accolade shows growing revenues but is still unprofitable. The company's personalized health platform has proven to be sticky to customers, but they are still reliant on key clients. Profitability and sustainable growth needs to be the focus. Competition is high with other navigation companies and large insurance companies, but expansion of their product offerings may drive growth.
Similar Companies
AMWL
American Well Corp
AMWL
American Well Corp
CLOV
Clover Health Investments Corp
CLOV
Clover Health Investments Corp
OSCR
Oscar Health Inc
OSCR
Oscar Health Inc
TDOC
Teladoc Inc
TDOC
Teladoc Inc
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Accolade Investor Relations Website
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market share data is based on estimates and may not be precise. Future performance is subject to various risks and uncertainties.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Accolade Inc
Exchange NASDAQ | Headquaters Seattle, WA, United States | ||
IPO Launch date 2020-07-02 | Chairman of the Board & CEO Mr. Rajeev Singh | ||
Sector Healthcare | Industry Health Information Services | Full time employees 2400 | Website https://www.accolade.com |
Full time employees 2400 | Website https://www.accolade.com | ||
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.